Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors

Title
Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors
Authors
Keywords
Phase 1 trial, APTO-253, KLF4, Solid tumors
Journal
INVESTIGATIONAL NEW DRUGS
Volume 33, Issue 5, Pages 1086-1092
Publisher
Springer Nature
Online
2015-08-13
DOI
10.1007/s10637-015-0273-z

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started